Ignite Creation Date:
2025-12-24 @ 1:19 PM
Ignite Modification Date:
2026-01-26 @ 4:05 AM
Study NCT ID:
NCT03776695
Status:
WITHDRAWN
Last Update Posted:
2022-03-24
First Post:
2018-12-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in ZIKV Infected Patients
Sponsor:
Tychan Pte Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-10-09
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-05
Completion Date Type:
ACTUAL
First Submit Date:
2018-12-12
First Submit QC Date:
None
Study First Post Date:
2018-12-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-08
Last Update Post Date:
2022-03-24
Last Update Post Date Type:
ACTUAL